Credit Suisse’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $418K | Buy |
93,461
+17,301
| +23% | +$77.3K | ﹤0.01% | 2707 |
|
|
2023
Q4 | $244K | Sell |
76,160
-8,982
| -11% | -$28.8K | ﹤0.01% | 2938 |
|
|
2023
Q3 | $270K | Sell |
85,142
-34,373
| -29% | -$109K | ﹤0.01% | 2955 |
|
|
2023
Q2 | $594K | Buy |
119,515
+13,675
| +13% | +$68K | ﹤0.01% | 2672 |
|
|
2023
Q1 | $523K | Buy |
105,840
+3,415
| +3% | +$16.9K | ﹤0.01% | 2718 |
|
|
2022
Q4 | $644K | Buy |
102,425
+20,108
| +24% | +$126K | ﹤0.01% | 2605 |
|
|
2022
Q3 | $889K | Buy |
82,317
+926
| +1% | +$10K | ﹤0.01% | 2396 |
|
|
2022
Q2 | $929K | Buy |
81,391
+13,898
| +21% | +$159K | ﹤0.01% | 2429 |
|
|
2022
Q1 | $615K | Buy |
67,493
+2,825
| +4% | +$25.7K | ﹤0.01% | 2835 |
|
|
2021
Q4 | $965K | Sell |
64,668
-13,399
| -17% | -$200K | ﹤0.01% | 2609 |
|
|
2021
Q3 | $2.01M | Buy |
78,067
+4,095
| +6% | +$105K | ﹤0.01% | 2145 |
|
|
2021
Q2 | $1.93M | Buy |
73,972
+11,683
| +19% | +$305K | ﹤0.01% | 2217 |
|
|
2021
Q1 | $2.2M | Sell |
62,289
-69,875
| -53% | -$2.47M | ﹤0.01% | 2077 |
|
|
2020
Q4 | $3.34M | Buy |
132,164
+15,797
| +14% | +$399K | ﹤0.01% | 1790 |
|
|
2020
Q3 | $4.39M | Sell |
116,367
-5,245
| -4% | -$198K | ﹤0.01% | 1362 |
|
|
2020
Q2 | $5.21M | Buy |
121,612
+47,806
| +65% | +$2.05M | ﹤0.01% | 1284 |
|
|
2020
Q1 | $1.43M | Sell |
73,806
-55,936
| -43% | -$1.09M | ﹤0.01% | 1867 |
|
|
2019
Q4 | $3.37M | Buy |
129,742
+110,462
| +573% | +$2.87M | ﹤0.01% | 1678 |
|
|
2019
Q3 | $525K | Buy |
19,280
+5,319
| +38% | +$145K | ﹤0.01% | 2774 |
|
|
2019
Q2 | $374K | Buy |
+13,961
| New | +$374K | ﹤0.01% | 2938 |
|